.: "arise: a phase 3 randomized trial of erenumab for episodic migraine."
.
.
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.
.. he wasn't certain, though, how much he'd be able to work before then.
.treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic)
.
. my profile